Cognizant has launched a Cyber Defence Centre (CDC) in Bengaluru, strengthening its global cybersecurity operations and expanding its ability to deliver advanced, AI-powered cybersecurity services to clients worldwide.
In a release, the company said the Bengaluru CDC is the company’s largest such facility, positioning it as a key hub within its global network of cyber defence centres.
It is designed to provide platform-centric cybersecurity managed services, along with cybersecurity engineering and transformation services, to enterprises across industries and geographies.
The company said the new centre is staffed by experienced cybersecurity professionals who will offer round-the-clock monitoring and rapid incident response.
To ensure a steady pipeline of skilled professionals, Cognizant said the centre has partnered with leading academic institutions to train next-generation cybersecurity talent.
The facility also houses an integrated threat research lab and is supported by leading technology companies.
“Cybersecurity is entering a new era where hyper-connected enterprises and AI-driven threats outpace traditional defences,” said Ravi Kumar S, CEO, Cognizant, stated in a release.
“Our new Cyber Defence Centre in Bengaluru reflects our commitment to delivering intelligence-led cybersecurity engineering and operation services that help enable clients to predict, prevent and mitigate advanced cybersecurity threats.”
According to Cognizant, the Bengaluru CDC is built on a multi-layered technology architecture that brings together the company’s proprietary innovations, including Cognizant Neuro Cybersecurity, with industry-leading platforms from technology partners to deliver advanced cybersecurity capabilities.
With the addition of the Bengaluru facility, the company said it is expanding the scale and depth of its global cyber defence centre network, aiming to deliver comprehensive enterprise cybersecurity services that help clients build risk resilience while advancing innovation in cyber defence strategies.
Your reaction
Discussion
What's your take on this story?
No comments yet — be the first to share your view.